The Academy of Military Medical Sciences' Drug Innovation Team Has Won consecutive Awards

　　This newspaper (reporter Zhang Wei) Recently, the Academy of Military Medicine the Academy of Toxics Drug Research Institute The Institute of Drug Synthesis Research Center was awarded the "Drug Innovation Model Research Office" honorary title by the Pla General Logistics Department It is understood that the research room is a 63-year glorious history of merit research room, has developed a series of anti-neurotoxic anti-drug anti-drug anti-drug antidote for chemical weapons damage, anti-toxic efficacy price is still the world's highest level; in recent years, the research room led by Liu Keliang, Li Song, Zhong Bohua drug innovation team , achieved a series of innovative results: the independent development of anti-flu virus special effects drug "junkoowe", the world's first suitable for the elderly, children and other special groups of people to use the "phosphate ostrich" Wei granules" have developed the first aid drug "Paramive injection" for critically ill patients, which makes China the first to have the world's most abundant influenza prevention and control drug system, which has played an important role in effectively containing the H5N1, H1N1, H7N9 influenza epidemic and saved the lives of many critically ill patients the drug innovation team presided over the completion of the world's most capable influenza prevention and control drug production line, with the world's unique advanced production technology, in a very short period of time to complete 26 million copies of drug production tasks, in the flu global outbreak of the crisis, for China's 1.3 billion people to reserve high-quality standards of "life-saving drugs", saving the country at least 5.8 billion yuan the drug innovation team developed the treatment of multi-drug-resistant bacteria infection drug "titacyclin", to fill the gap in this field of china's drugs, is currently the last line of defense against "superbug" infection, for the protection of national public health security to provide strategic drug security, only last year successfully treated more than a thousand cases of drug-resistant serious patients the drug innovation team created a new anti-neurotoxic antidote antidote technology, the production cycle from 720 days to 20 days, greatly improving China's ability to respond to sudden chemical terrorist incidents; the drug innovation team to break the monopoly, developed China's independent intellectual property rights, the people can afford the "people's livelihood medicine" - the treatment of type 2 diabetes drug "Taro" "Taro" because of its low price, significant efficacy and strict quality standards, become a veritable "affordable medicine", "people's livelihood medicine", for china's more than 100 million diabetics to reduce the burden of drug costs 70%, an average of more than 3000 yuan per person per year Not only that, "Tailo" also broke the patent monopoly of foreign pharmaceutical companies, can be called China's scientific research institutions and production enterprises using patented weapons to successfully break the foreign blockade of the model, so that national pharmaceutical enterprises waist bar more hard, more sufficient the drug innovation team adhere to innovation, and constantly develop their own brand of "original medicine." With the support of several major projects of the state and the army, they have been developing imitation drugs and industrialization of innovative drug research, scientific research strength has been continuously enhanced, and gradually established a world-class scientific research platform to accelerate the "Made in China" to "Created in China" the drug innovation team built the most powerful drug design in China's trillion-time cluster computer system Computer virtual high-throughput screening work based on this platform has improved thousands of times more than traditional compound screening efficiency, has successfully contributed to the research and development of five innovative drugs, achieving a market value of nearly 12 billion yuan; in recent years, the research room has applied for 153 invention patents, China, the United States, the European Union and other countries and regions authorized 110 patents, won the National Invention Patent Gold Award 1, the National New Drug Certificate 27 and the National Science and Technology Progress Award first prize, the National Technology Invention Award second prize and other high-level awards 10, become the most dynamic and contributing to the domestic innovative drug research one of the most dynamic and contributing teams (Responsible Editor: HN025) ,